Inhaled pulmonary vasodilators for persistent pulmonary hypertension of the newborn: safety issues relating to drug administration and delivery devices

Treatment for persistent pulmonary hypertension of the newborn (PPHN) aims to reduce pulmonary vascular resistance while maintaining systemic vascular resistance. Selective pulmonary vasodilation may be achieved by targeting pulmonary-specific pathways or by delivering vasodilators directly to the l...

Descripción completa

Detalles Bibliográficos
Autores principales: Cosa, Nathan, Costa, Edward
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4835137/
https://www.ncbi.nlm.nih.gov/pubmed/27110141
http://dx.doi.org/10.2147/MDER.S99601

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4835137/
https://www.ncbi.nlm.nih.gov/pubmed/27110141
http://dx.doi.org/10.2147/MDER.S99601

Ejemplares similares